Quarterly report pursuant to Section 13 or 15(d)

9. Segment and Geographic Information

v3.5.0.2
9. Segment and Geographic Information
 3 Months Ended
Jun. 30, 2016
Segment Reporting [Abstract]  
Segment and Geographic Information

The Company generates product revenues from wound care products that are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services, which are provided to medical device manufacturers.

 

 

The Company operates a single segment business for product revenues, which consists of three geographical sales territories as follows:

 

    Three Months Ended June 30,  
    2016     2015  
United States   $ 1,373,000     $ 787,000  
Latin America     1,098,000       1,558,000  
Europe and Rest of the World     1,038,000       571,000  
      3,509,000       2,916,000  
Product license fees and royalties     75,000       447,000  
Total   $ 3,584,000     $ 3,363,000  

 

The following table shows the Company’s product license fees and royalties revenues by partner:

  

    Three Months Ended June 30,  
Product license fees and royalties   2016     2015  
Exeltis   $ –     $ 54,000  
Innovacyn     –       20,000  
Laboratorios Sanfer, S.A. de C.V.     75,000       373,000  
Total product license fees and royalties   $ 75,000     $ 447,000  

 

The Company’s service revenues amounted to $227,000 and $317,000 for the three months ended June 30, 2016 and 2015, respectively.